UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000048031
Receipt number R000054745
Scientific Title Effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients: A Randomized Clinical Trial
Date of disclosure of the study information 2022/06/25
Last modified on 2022/06/13 18:49:00

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients: A Randomized Clinical Trial

Acronym

BETA CELL FUNCTION OR INSULIN SECRETION (HOMA B)
The amount of glucose cleared from the blood in response to a dose of insulin. A score of less than 100 defined reduced B cell function.

INSULIN RESISTANCE (HOMA IR)
Defined as a condition when normal amount of insulin in body fails to produce the desired response . A score of greater than or equal to 2.0 defined IR.

INSULIN SENSITIVITY
Insulin sensitivity calculate by using the following formula is IS equal to 1 per IR (Normal is less than 3.0)

VITAMIN D STATUS
Vitamin D status was defined as SUFFICIENT with level of vitamin D greater than 30ng per ml and DEFICIENT with level of serum 25 (OH) vit D less than or equal to 30ng per ml.

Scientific Title

Effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients: A Randomized Clinical Trial

Scientific Title:Acronym

BETA CELL FUNCTION OR INSULIN SECRETION (HOMA B)
The amount of glucose cleared from the blood in response to a dose of insulin. A score of less than 100 defined reduced B cell function.

INSULIN RESISTANCE (HOMA IR)
Defined as a condition when normal amount of insulin in body fails to produce the desired response . A score of greater than or equal to 2.0 defined IR.

INSULIN SENSITIVITY
Insulin sensitivity calculate by using the following formula is IS equal to 1 per IR (Normal is less than 3.0)

VITAMIN D STATUS
Vitamin D status was defined as SUFFICIENT with level of vitamin D greater than 30ng per ml and DEFICIENT with level of serum 25 (OH) vit D less than or equal to 30ng per ml.

Region

Asia(except Japan)


Condition

Condition

Type 2 Diabetic patients

Classification by specialty

Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To examine the effect of vitamin D supplementation on glucose homeostasis among Type 2 Diabetic patients by comparing treatment and control group both at baseline and end line

Basic objectives2

Others

Basic objectives -Others

SPECIFIC OBJECTIVES (FOR BOTH TREATMENT AND CONTROL GROUP)
1. Assessment of the socio-demographic characteristics

2. Assessment of nutritional status with anthropometric parameters.

3. Advising, monitoring and controlling the diabetes diet and physical activity.

4. Analyzing different biochemical profile -
- Vitamin D
- Fasting Blood Glucose (FBG)
- Fasting blood insulin (FBI)
- Derived parameter Homeostatic model assessment (HOMA) for beta-cell function, Insulin sensitivity (IS) and insulin resistance (IR)
- HbA1c (Glycated Haemoglobin A1C)
- Serum calcium
- C-reactive protein (CRP)
- MDA (malondialdehyde) and
- SOD (Superoxide dismutase)

5. To find out the influence of vitamin D on
- Fasting blood Insulin (FBI) level
- Fasting blood glucose (FBG) level
- Glycated hemoglobin (HbA1c or A1c) level
- Stress-marker like Malondialdehyde (MDA) and Super-oxide Dismutase level (SOD)
- Serum Calcium and
- Inflammatory-marker like C-reactive protein (CRP) level

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

HYPOTHESIS - ACCEPTED
1. Vitamin D supplementation for 12 weeks would improve glycemic indices of HbA1c among Type 2 diabetic patients as compared to placebo group

2. Vitamin D supplementation for 12 weeks would improve glycemic indices of fasting blood glucose among Type 2 diabetic patients as compared to placebo group

Key secondary outcomes

HYPOTHESIS - REJECTED
1. Vitamin D supplementation for 12 weeks would improve fasting Plasma Insulin.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Placebo

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine Food Behavior,custom

Interventions/Control_1

Vitamin D Supplementation

Interventions/Control_2

Placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

30 years-old <=

Age-upper limit

70 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Type 2 diabetic patients of aged 30 year to 70 year who were in treatment of oral hypoglycemic agent.
2. Agreed to maintain their usual dietary and physical activity habits at the time of intervention.
3. Voluntarily willing to participate in this clinical study.

Key exclusion criteria

1. Below 30 years or above 70 years of age with Type I Diabetes Mellitus on insulin
2. Consuming vitamin D supplements within 3 months before beginning of the study
3. Women patients who were pregnant or breastfeeding

Target sample size

146


Research contact person

Name of lead principal investigator

1st name Nadia
Middle name
Last name Begum

Organization

University of Dhaka, Bangladesh

Division name

Institute of Nutrition and Food Science

Zip code

1207

Address

Apartment No. 3A, House No. 409, Road No. 5, Adabor, Dhaka, Bangladesh

TEL

+8801712929996

Email

nadiabegum.zhs@gmail.com


Public contact

Name of contact person

1st name Nadia
Middle name
Last name Begum

Organization

University of Dhaka, Bangladesh

Division name

Institute of Nutrition and Food Science

Zip code

1207

Address

Apartment No. 3A, House No. 409, Road No. 5, Adabor, Dhaka, Bangladesh

TEL

+8801712929996

Homepage URL


Email

nadiabegum.zhs@gmail.com


Sponsor or person

Institute

University of Dhaka, Bangladesh


University of Dhaka, Bangladesh


Institute of Nutrition and Food Science

Institute

Department

Personal name



Funding Source

Organization

Ministry of Science and Technology


Ministry of Science and Technology


Bangabandhu Science and Technology Fellowship Trust

Organization

Division

Category of Funding Organization

Government offices of other countries

Nationality of Funding Organization

Bangladeshi


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institute of Nutrition and Food Science, University of Dhaka

Address

Dhaka University Campus, Dhaka-1000

Tel

+88 02 9661920-73 (Ext 8400, 8401)

Email

infs@du.ac.bd


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 06 Month 25 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 28 Day

Date of IRB

2017 Year 01 Month 16 Day

Anticipated trial start date

2019 Year 05 Month 02 Day

Last follow-up date

2021 Year 12 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 06 Month 11 Day

Last modified on

2022 Year 06 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054745